ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
TRAWS PHARMA
2.02
-0.1800
-8.18%
盤後:
2.02
0.0000
0.00%
16:10 EDT
成交量:
4.23萬
成交額:
8.73萬
市值:
1,614.16萬
市盈率:
-1.11
高:
2.24
開:
2.18
低:
1.98
收:
2.20
52周最高:
3.27
52周最低:
0.9700
股本:
799.09萬
流通股本:
592.57萬
量比:
0.24
換手率:
0.71%
股息:
- -
股息率:
- -
每股收益(TTM):
-1.8200
每股收益(LYR):
-35.2126
淨資產收益率:
-1059.63%
總資產收益率:
-92.29%
市淨率:
3.55
市盈率(LYR):
-0.06
資料載入中...
總覽
公司
新聞資訊
公告
Traws Pharma, Inc.盤中異動 早盤大幅上漲5.10%報1.65美元
市场透视
·
02/20
Traws Pharma, Inc.股價重挫21.57% 市值跌266.3萬美元
市场透视
·
02/19
BUZZ-Traws Pharma 因 FDA 將流感藥物申請臨床擱置而下跌
路透中文
·
02/19
TRAWS PHARMA:美國FDA計劃於3月16日前正式傳達其關切及建議緩解措施
美股速递
·
02/19
Traws藥業完成Ratutrelvir在適用與不適用Paxlovid®的新冠患者中的臨床研究分析,並更新Tivoxavir Marboxil作為季節性流感預防性治療的附加適應症
美股速递
·
02/19
Traws Pharma, Inc.盤中異動 大幅上漲5.36%報2.07美元
市场透视
·
02/18
Traws Pharma, Inc.盤中異動 早盤股價大跌5.69%報1.82美元
市场透视
·
02/11
Traws藥業完成Ratutrelvir在適用與不適用Paxlovid®的新冠患者中的臨床研究入組;宣佈計劃為Tivoxavir Marboxil新增季節性流感預防性治療適應症
美股速递
·
01/26
Traws Pharma, Inc.盤中異動 急速下挫5.59%
市场透视
·
01/15
Traws Pharma Inc:Ratutrelvir展現出與Paxlovid™的顯著不同的特徵,副作用更少且未出現病毒反彈
美股速递
·
2025/12/17
TRAWS PHARMA公布Ratutrelvir與Paxlovid™對比的積極中期臨床數據,顯示對不適合使用Paxlovid患者的療效
美股速递
·
2025/12/17
Traws Pharma, Inc.盤中異動 早盤急速拉升6.17%
市场透视
·
2025/11/25
Traws Pharma, Inc.盤中異動 快速拉升12.25%報2.19美元
市场透视
·
2025/11/10
Chemdiv擴展與TRAWS PHARMA的Ratutrelvir的CMC服務合作,後者是一個在進行二期臨床試驗的潛在最佳Covid-19治療藥物
美股速递
·
2025/10/31
TRAWS PHARMA啓動Ratutrelvir二期新冠研究,首位患者已接受給藥,預計2025年底公布結果
美股速递
·
2025/10/14
TRAWS PHARMA任命John Leaman醫學博士為獨立董事,並正式確認兩名核心高管職務
美股速递
·
2025/10/06
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/TRAW/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TRAW","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAW\",,,,,undefined,":{"symbol":"TRAW","market":"US","secType":"STK","nameCN":"TRAWS PHARMA","latestPrice":2.02,"timestamp":1773864000000,"preClose":2.2,"halted":0,"volume":42334,"hourTrading":{"tag":"盘后","latestPrice":2.02,"preClose":2.02,"latestTime":"16:10 EDT","volume":2,"amount":4.04,"timestamp":1773864605097,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.08181818181818189,"floatShares":5925700,"shares":7990867,"eps":-1.82,"marketStatus":"未開盤","change":-0.18,"latestTime":"03-18 16:00:00 EDT","open":2.18,"high":2.2368,"low":1.975,"amount":87252.0771,"amplitude":0.119,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.82,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1773907200000},"marketStatusCode":0,"adr":0,"listingDate":1374724800000,"exchange":"NASDAQ","adjPreClose":2.2,"preHourTrading":{"tag":"盘前","latestPrice":2.21,"preClose":2.2,"latestTime":"09:29 EDT","volume":421,"amount":910.5401472,"timestamp":1773840598018,"change":0.01,"changeRate":0.004545,"amplitude":0.027273},"postHourTrading":{"tag":"盘后","latestPrice":2.02,"preClose":2.02,"latestTime":"16:10 EDT","volume":2,"amount":4.04,"timestamp":1773864605097,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.239618,"impliedVol":1.6331,"impliedVolPercentile":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRAW\",,,,,undefined,":{"symbol":"TRAW","floatShares":5925700,"roa":"-92.29%","roe":"-1059.63%","lyrEps":-35.212551,"volumeRatio":0.239618,"shares":7990867,"dividePrice":0,"high":2.2368,"amplitude":0.119,"preClose":2.2,"low":1.975,"week52Low":0.97,"pbRate":"3.55","psRate":"5.67","week52High":3.265,"institutionHeld":0,"latestPrice":2.02,"eps":-1.82,"divideRate":0,"volume":42334,"delay":0,"ttmEps":-1.82,"open":2.18,"prevYearClose":1.13,"prevWeekClose":2,"prevMonthClose":1.65,"prevQuarterClose":1.13,"fiveDayClose":1.99,"twentyDayClose":1.97,"sixtyDayClose":1.25},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRAW\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"TRAW","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"pre","actualEps":-0.34},{"market":"US","date":"2025-08-14","symbol":"TRAW","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1755144000000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2025-05-15","symbol":"TRAW","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1747281600000,"reportTimeType":"pre","actualEps":2.09},{"market":"US","date":"2025-03-31","symbol":"TRAW","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"pre","actualEps":95.66},{"market":"US","date":"2024-11-14","symbol":"TRAW","fiscalQuarterEnding":"2024/09","expectedEps":-6.25,"name":null,"time":"盤後","type":"earning","dateTimestamp":1731560400000,"reportTimeType":"post","actualEps":-8.81}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRAW\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRAW\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1764820800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRAW\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRAW","date":"2026-03-17","current":-1.120879,"percent":0.053305,"low":-1.693158,"twenty":-0.868603,"median":-0.175166,"eighty":-0.064632,"high":-0.033516,"avg":-0.469036,"sd":0.449168,"marketCap":16860729},"quantilePoints":[{"date":"2024-04-05","current":-0.930105,"twenty":-0.930105,"median":-0.930105,"eighty":-0.930105,"marketCap":17623624},{"date":"2024-04-12","current":-0.875242,"twenty":-0.899279,"median":-0.879971,"eighty":-0.87246,"marketCap":16584087},{"date":"2024-04-19","current":-0.774197,"twenty":-0.884701,"median":-0.859217,"eighty":-0.774642,"marketCap":14669484},{"date":"2024-04-26","current":-0.703922,"twenty":-0.875242,"median":-0.784323,"eighty":-0.745597,"marketCap":13337908},{"date":"2024-05-03","current":-0.713993,"twenty":-0.87246,"median":-0.75973,"eighty":-0.713993,"marketCap":13528735},{"date":"2024-05-10","current":-0.722239,"twenty":-0.859217,"median":-0.743093,"eighty":-0.71377,"marketCap":13684982},{"date":"2024-05-17","current":-0.7463,"twenty":-0.799236,"median":-0.738475,"eighty":-0.713993,"marketCap":13549821},{"date":"2024-05-24","current":-0.73457,"twenty":-0.794005,"median":-0.741761,"eighty":-0.718444,"marketCap":13336853},{"date":"2024-05-31","current":-0.675921,"twenty":-0.778515,"median":-0.736522,"eighty":-0.713681,"marketCap":12272014},{"date":"2024-06-07","current":-0.836261,"twenty":-0.794624,"median":-0.73457,"eighty":-0.711322,"marketCap":15183160},{"date":"2024-06-14","current":-0.873049,"twenty":-0.83888,"median":-0.740589,"eighty":-0.71288,"marketCap":15851082},{"date":"2024-06-21","current":-0.649387,"twenty":-0.836845,"median":-0.738475,"eighty":-0.709541,"marketCap":11790270},{"date":"2024-06-28","current":-0.62709,"twenty":-0.83835,"median":-0.738475,"eighty":-0.706993,"marketCap":11385454},{"date":"2024-07-05","current":-0.557395,"twenty":-0.836651,"median":-0.734469,"eighty":-0.698614,"marketCap":10120072},{"date":"2024-07-12","current":-0.483661,"twenty":-0.814046,"median":-0.728873,"eighty":-0.672205,"marketCap":8781358},{"date":"2024-07-15","current":-0.554747,"twenty":-0.806641,"median":-0.726171,"eighty":-0.663181,"marketCap":10071990},{"date":"2024-08-02","current":-0.532446,"twenty":-0.799236,"median":-0.724978,"eighty":-0.649387,"marketCap":9667086},{"date":"2024-08-09","current":-0.491259,"twenty":-0.797102,"median":-0.722239,"eighty":-0.600613,"marketCap":8919304},{"date":"2024-08-16","current":-0.066488,"twenty":-0.794005,"median":-0.718444,"eighty":-0.532446,"marketCap":9112137},{"date":"2024-08-23","current":-0.065565,"twenty":-0.774642,"median":-0.71377,"eighty":-0.508851,"marketCap":8985580},{"date":"2024-08-30","current":-0.06743,"twenty":-0.774197,"median":-0.709986,"eighty":-0.494812,"marketCap":9241226},{"date":"2024-09-06","current":-0.06538,"twenty":-0.762623,"median":-0.702951,"eighty":-0.490604,"marketCap":8960268},{"date":"2024-09-13","current":-0.062794,"twenty":-0.758648,"median":-0.694503,"eighty":-0.071087,"marketCap":8605907},{"date":"2024-09-20","current":-0.057254,"twenty":-0.751084,"median":-0.683063,"eighty":-0.068232,"marketCap":7846562},{"date":"2024-09-27","current":-0.081301,"twenty":-0.74722,"median":-0.649387,"eighty":-0.067774,"marketCap":11142278},{"date":"2024-10-04","current":-0.073971,"twenty":-0.746382,"median":-0.624791,"eighty":-0.068232,"marketCap":10137646},{"date":"2024-10-11","current":-0.065174,"twenty":-0.745738,"median":-0.557395,"eighty":-0.067596,"marketCap":8932088},{"date":"2024-10-18","current":-0.062642,"twenty":-0.744673,"median":-0.543597,"eighty":-0.067316,"marketCap":8585034},{"date":"2024-10-25","current":-0.111702,"twenty":-0.743234,"median":-0.515682,"eighty":-0.066488,"marketCap":15308680},{"date":"2024-10-31","current":-0.109715,"twenty":-0.741526,"median":-0.508851,"eighty":-0.066652,"marketCap":15036392},{"date":"2024-11-08","current":-0.111592,"twenty":-0.739321,"median":-0.498158,"eighty":-0.06682,"marketCap":15293553},{"date":"2024-11-15","current":-0.123204,"twenty":-0.736132,"median":-0.492107,"eighty":-0.067201,"marketCap":16884930},{"date":"2024-11-22","current":-0.096923,"twenty":-0.734509,"median":-0.489621,"eighty":-0.06743,"marketCap":13645248},{"date":"2024-11-29","current":-0.098427,"twenty":-0.734469,"median":-0.48099,"eighty":-0.067496,"marketCap":13857037},{"date":"2024-12-06","current":-0.108407,"twenty":-0.733312,"median":-0.130241,"eighty":-0.067596,"marketCap":15262104},{"date":"2024-12-13","current":-0.104014,"twenty":-0.729414,"median":-0.121316,"eighty":-0.067685,"marketCap":14643681},{"date":"2024-12-20","current":-0.114642,"twenty":-0.725217,"median":-0.114642,"eighty":-0.068025,"marketCap":16139817},{"date":"2024-12-27","current":-0.244993,"twenty":-0.723719,"median":-0.117501,"eighty":-0.068353,"marketCap":34491315},{"date":"2025-01-03","current":-0.186323,"twenty":-0.723452,"median":-0.123204,"eighty":-0.068427,"marketCap":26231553},{"date":"2025-01-10","current":-0.173429,"twenty":-0.722482,"median":-0.130241,"eighty":-0.069344,"marketCap":24416220},{"date":"2025-01-17","current":-0.146996,"twenty":-0.721141,"median":-0.147157,"eighty":-0.069786,"marketCap":20694789},{"date":"2025-01-24","current":-0.13797,"twenty":-0.719413,"median":-0.140763,"eighty":-0.070056,"marketCap":19424056},{"date":"2025-01-31","current":-0.156666,"twenty":-0.718444,"median":-0.146996,"eighty":-0.070643,"marketCap":22056288},{"date":"2025-02-07","current":-0.178157,"twenty":-0.715773,"median":-0.153981,"eighty":-0.07105,"marketCap":25081842},{"date":"2025-02-14","current":-0.173739,"twenty":-0.713859,"median":-0.157526,"eighty":-0.072709,"marketCap":24459897},{"date":"2025-02-21","current":-0.121618,"twenty":-0.713592,"median":-0.156666,"eighty":-0.073848,"marketCap":17121928},{"date":"2025-02-28","current":-0.087129,"twenty":-0.71288,"median":-0.149414,"eighty":-0.074131,"marketCap":12266456},{"date":"2025-03-07","current":-0.070533,"twenty":-0.710432,"median":-0.144632,"eighty":-0.071013,"marketCap":9929988},{"date":"2025-03-14","current":-0.07157,"twenty":-0.706225,"median":-0.135069,"eighty":-0.071013,"marketCap":10076017},{"date":"2025-03-21","current":-0.074682,"twenty":-0.703145,"median":-0.130241,"eighty":-0.070984,"marketCap":10514105},{"date":"2025-03-28","current":-0.066643,"twenty":-0.70173,"median":-0.123448,"eighty":-0.070533,"marketCap":9382378},{"date":"2025-04-04","current":-0.066422,"twenty":-0.698614,"median":-0.121618,"eighty":-0.069679,"marketCap":11060862},{"date":"2025-04-11","current":-0.053321,"twenty":-0.692996,"median":-0.117957,"eighty":-0.068372,"marketCap":8879132},{"date":"2025-04-17","current":-0.060633,"twenty":-0.690629,"median":-0.115407,"eighty":-0.067596,"marketCap":10096842},{"date":"2025-04-25","current":-0.046618,"twenty":-0.687348,"median":-0.111751,"eighty":-0.066971,"marketCap":7762898},{"date":"2025-05-02","current":-0.042961,"twenty":-0.674063,"median":-0.111618,"eighty":-0.066488,"marketCap":7154043},{"date":"2025-05-09","current":-0.042657,"twenty":-0.663181,"median":-0.111481,"eighty":-0.065417,"marketCap":7103306},{"date":"2025-05-16","current":-0.033516,"twenty":-0.647743,"median":-0.11053,"eighty":-0.064788,"marketCap":5581169},{"date":"2025-05-23","current":-0.045648,"twenty":-0.63835,"median":-0.110157,"eighty":-0.064588,"marketCap":6392975},{"date":"2025-05-30","current":-0.055226,"twenty":-0.62709,"median":-0.109384,"eighty":-0.063348,"marketCap":7734397},{"date":"2025-06-06","current":-0.058802,"twenty":-0.622492,"median":-0.108696,"eighty":-0.062794,"marketCap":8235186},{"date":"2025-06-13","current":-0.071516,"twenty":-0.600613,"median":-0.107668,"eighty":-0.063175,"marketCap":10015767},{"date":"2025-06-20","current":-0.065556,"twenty":-0.566039,"median":-0.107023,"eighty":-0.063313,"marketCap":9181119},{"date":"2025-06-27","current":-0.056815,"twenty":-0.557298,"median":-0.10387,"eighty":-0.062794,"marketCap":7956970},{"date":"2025-07-03","current":-0.05761,"twenty":-0.555758,"median":-0.101756,"eighty":-0.062399,"marketCap":8068256},{"date":"2025-07-11","current":-0.062378,"twenty":-0.541366,"median":-0.099933,"eighty":-0.061976,"marketCap":8735974},{"date":"2025-07-18","current":-0.064364,"twenty":-0.529937,"median":-0.097675,"eighty":-0.061583,"marketCap":9014190},{"date":"2025-07-25","current":-0.064761,"twenty":-0.520715,"median":-0.095947,"eighty":-0.061819,"marketCap":9069833},{"date":"2025-08-01","current":-0.061186,"twenty":-0.513446,"median":-0.092228,"eighty":-0.061583,"marketCap":8569045},{"date":"2025-08-08","current":-0.058802,"twenty":-0.510093,"median":-0.087897,"eighty":-0.061164,"marketCap":8235186},{"date":"2025-08-15","current":-0.50579,"twenty":-0.507369,"median":-0.086481,"eighty":-0.061164,"marketCap":9014190},{"date":"2025-08-22","current":-0.546969,"twenty":-0.527596,"median":-0.090759,"eighty":-0.061186,"marketCap":9748084},{"date":"2025-08-29","current":-0.562823,"twenty":-0.55008,"median":-0.094773,"eighty":-0.061424,"marketCap":10030637},{"date":"2025-09-05","current":-0.65993,"twenty":-0.557347,"median":-0.096218,"eighty":-0.061583,"marketCap":11761275},{"date":"2025-09-12","current":-0.717402,"twenty":-0.561238,"median":-0.098427,"eighty":-0.061583,"marketCap":12785530},{"date":"2025-09-19","current":-0.81649,"twenty":-0.587397,"median":-0.100444,"eighty":-0.06174,"marketCap":14551487},{"date":"2025-09-26","current":-0.745146,"twenty":-0.633715,"median":-0.10251,"eighty":-0.061976,"marketCap":13279998},{"date":"2025-10-03","current":-0.721365,"twenty":-0.66395,"median":-0.104979,"eighty":-0.061978,"marketCap":12856168},{"date":"2025-10-10","current":-1.240589,"twenty":-0.692996,"median":-0.107234,"eighty":-0.06201,"marketCap":22109784},{"date":"2025-10-17","current":-1.058266,"twenty":-0.706225,"median":-0.108145,"eighty":-0.062128,"marketCap":18860423},{"date":"2025-10-24","current":-1.051562,"twenty":-0.713592,"median":-0.109053,"eighty":-0.062292,"marketCap":18740938},{"date":"2025-10-31","current":-1.05556,"twenty":-0.718444,"median":-0.109936,"eighty":-0.06243,"marketCap":18812196},{"date":"2025-11-07","current":-0.809663,"twenty":-0.722967,"median":-0.110382,"eighty":-0.062562,"marketCap":14429809},{"date":"2025-11-14","current":-0.707705,"twenty":-0.726854,"median":-0.111401,"eighty":-0.062695,"marketCap":12612722},{"date":"2025-11-21","current":-1.284879,"twenty":-0.733984,"median":-0.111592,"eighty":-0.062775,"marketCap":17100455},{"date":"2025-11-28","current":-1.621109,"twenty":-0.736689,"median":-0.111702,"eighty":-0.062779,"marketCap":21575340},{"date":"2025-12-05","current":-1.416969,"twenty":-0.741064,"median":-0.113304,"eighty":-0.062794,"marketCap":18858446},{"date":"2025-12-12","current":-1.398957,"twenty":-0.745146,"median":-0.117501,"eighty":-0.062794,"marketCap":18618720},{"date":"2025-12-19","current":-0.750513,"twenty":-0.74863,"median":-0.120524,"eighty":-0.06287,"marketCap":9988583},{"date":"2025-12-26","current":-0.744509,"twenty":-0.74911,"median":-0.123065,"eighty":-0.063175,"marketCap":9908675},{"date":"2026-01-02","current":-0.678464,"twenty":-0.74911,"median":-0.12421,"eighty":-0.063313,"marketCap":9029679},{"date":"2026-01-09","current":-0.846579,"twenty":-0.755955,"median":-0.131212,"eighty":-0.063525,"marketCap":11267122},{"date":"2026-01-16","current":-1.032707,"twenty":-0.760288,"median":-0.140763,"eighty":-0.063894,"marketCap":13744291},{"date":"2026-01-23","current":-1.495023,"twenty":-0.77433,"median":-0.145814,"eighty":-0.063975,"marketCap":19897258},{"date":"2026-01-30","current":-1.260863,"twenty":-0.780019,"median":-0.151509,"eighty":-0.064208,"marketCap":16780820},{"date":"2026-02-06","current":-1.032707,"twenty":-0.795244,"median":-0.157096,"eighty":-0.064364,"marketCap":13744291},{"date":"2026-02-13","current":-1.152789,"twenty":-0.80455,"median":-0.158601,"eighty":-0.064364,"marketCap":15342464},{"date":"2026-02-20","current":-0.942645,"twenty":-0.811381,"median":-0.160965,"eighty":-0.064364,"marketCap":12545661},{"date":"2026-02-27","current":-0.972665,"twenty":-0.836845,"median":-0.164538,"eighty":-0.064453,"marketCap":12945204},{"date":"2026-03-06","current":-0.960657,"twenty":-0.845071,"median":-0.17085,"eighty":-0.064589,"marketCap":12785387},{"date":"2026-03-13","current":-1.21283,"twenty":-0.86427,"median":-0.173584,"eighty":-0.064613,"marketCap":16141551},{"date":"2026-03-17","current":-1.266867,"twenty":-0.868603,"median":-0.175166,"eighty":-0.064632,"marketCap":16860729}],"updateTime":1773852583808},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRAW\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2613995122","title":"Traws Pharma, Inc.盤中異動 早盤大幅上漲5.10%報1.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2613995122","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2613995122?lang=zh_tw&edition=fundamental","pubTime":"2026-02-20 22:49","pubTimestamp":1771598978,"startTime":"0","endTime":"0","summary":"北京时间2026年02月20日22时49分,Traws Pharma, Inc.股票出现波动,股价急速拉升5.10%。截至发稿,该股报1.65美元/股,成交量1.4331万股,换手率0.18%,振幅7.64%。Traws Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.24%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家临床阶段的生物制药公司,致力于开发新型疗法,以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022022493897a69459&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026022022493897a69459&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2612253949","title":"Traws Pharma, Inc.股價重挫21.57% 市值跌266.3萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612253949","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612253949?lang=zh_tw&edition=fundamental","pubTime":"2026-02-19 22:31","pubTimestamp":1771511472,"startTime":"0","endTime":"0","summary":"北京时间2026年02月19日22时31分,Traws Pharma, Inc.股票出现波动,股价急速下跌21.57%。Traws Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.34%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家临床阶段的生物制药公司,致力于开发新型疗法,以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219223112a70a7ccf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260219223112a70a7ccf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2612400624","title":"BUZZ-Traws Pharma 因 FDA 將流感藥物申請臨床擱置而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2612400624","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612400624?lang=zh_tw&edition=fundamental","pubTime":"2026-02-19 21:18","pubTimestamp":1771507092,"startTime":"0","endTime":"0","summary":"BUZZ-Traws Pharma 因 FDA 将流感药物申请临床搁置而下跌2月19日 - ** Traws Pharma TRAW.O股价盘前下跌20.81%,报1.58美元** 该公司称,美国 FDA 将其用于预防季节性流感的单片口服片剂 tivoxavir marboxil 的新药临床试验申请 搁置。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nL4S3ZF10H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"1177154585","title":"TRAWS PHARMA:美國FDA計劃於3月16日前正式傳達其關切及建議緩解措施","url":"https://stock-news.laohu8.com/highlight/detail?id=1177154585","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177154585?lang=zh_tw&edition=fundamental","pubTime":"2026-02-19 20:32","pubTimestamp":1771504331,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局(FDA)已向TRAWS PHARMA公司表明,其计划在3月16日之前,就相关事宜正式传达其监管关切。此次沟通将不仅明确指出FDA所关注的问题,还将附带一系列建议的缓解步骤,旨在为该公司提供明确的指引路径。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"1101675571","title":"Traws藥業完成Ratutrelvir在適用與不適用Paxlovid®的新冠患者中的臨床研究分析,並更新Tivoxavir Marboxil作為季節性流感預防性治療的附加適應症","url":"https://stock-news.laohu8.com/highlight/detail?id=1101675571","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101675571?lang=zh_tw&edition=fundamental","pubTime":"2026-02-19 20:31","pubTimestamp":1771504277,"startTime":"0","endTime":"0","summary":"Traws药业已成功完成其候选药物Ratutrelvir针对适用与不适用Paxlovid®治疗的新冠肺炎患者的临床研究数据分析。此项分析为评估该药物在不同患者群体中的疗效与安全性提供了关键见解。\n同时,公司宣布更新其另一款药物Tivoxavir Marboxil的研发进展,该药物正在寻求作为季节性流感的预防性治疗新适应症。这一进展标志着Traws药业在抗病毒治疗领域同时推进多项研发计划,旨在应对新冠病毒和季节性流感带来的公共卫生挑战。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2612547862","title":"Traws Pharma, Inc.盤中異動 大幅上漲5.36%報2.07美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612547862","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612547862?lang=zh_tw&edition=fundamental","pubTime":"2026-02-18 22:30","pubTimestamp":1771425059,"startTime":"0","endTime":"0","summary":"北京时间2026年02月18日22时30分,Traws Pharma, Inc.股票出现异动,股价快速上涨5.36%。Traws Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.00%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家临床阶段的生物制药公司,致力于开发新型疗法,以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218223059a7077554&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260218223059a7077554&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007","SNSE","BK4139"],"gpt_icon":0},{"id":"2610851910","title":"Traws Pharma, Inc.盤中異動 早盤股價大跌5.69%報1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610851910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610851910?lang=zh_tw&edition=fundamental","pubTime":"2026-02-11 23:50","pubTimestamp":1770825012,"startTime":"0","endTime":"0","summary":"北京时间2026年02月11日23时50分,Traws Pharma, Inc.股票出现波动,股价快速下跌5.69%。截至发稿,该股报1.82美元/股,成交量1.9131万股,换手率0.24%,振幅5.66%。Traws Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.77%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家临床阶段的生物制药公司,致力于开发新型疗法,以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211235012a6ef9df6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260211235012a6ef9df6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"1112787706","title":"Traws藥業完成Ratutrelvir在適用與不適用Paxlovid®的新冠患者中的臨床研究入組;宣佈計劃為Tivoxavir Marboxil新增季節性流感預防性治療適應症","url":"https://stock-news.laohu8.com/highlight/detail?id=1112787706","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112787706?lang=zh_tw&edition=fundamental","pubTime":"2026-01-26 21:32","pubTimestamp":1769434340,"startTime":"0","endTime":"0","summary":"Traws药业已顺利完成其候选药物Ratutrelvir针对适用及不适用Paxlovid®的新冠病毒感染者的临床试验患者招募工作。\n与此同时,该公司宣布将拓展其另一款药物Tivoxavir Marboxil的适应症范围,计划将其开发为季节性流感的预防性治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2603603079","title":"Traws Pharma, Inc.盤中異動 急速下挫5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603603079","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603603079?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 01:14","pubTimestamp":1768410894,"startTime":"0","endTime":"0","summary":"北京时间2026年01月15日01时14分,Traws Pharma, Inc.股票出现波动,股价快速下挫5.59%。Traws Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.07%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家临床阶段的生物制药公司,致力于开发新型疗法,以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115011454953ccbb7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260115011454953ccbb7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"1105664831","title":"Traws Pharma Inc:Ratutrelvir展現出與Paxlovid™的顯著不同的特徵,副作用更少且未出現病毒反彈","url":"https://stock-news.laohu8.com/highlight/detail?id=1105664831","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105664831?lang=zh_tw&edition=fundamental","pubTime":"2025-12-17 19:12","pubTimestamp":1765969962,"startTime":"0","endTime":"0","summary":"Traws Pharma Inc:Ratutrelvir展现出与Paxlovid™的显著不同的特征,副作用更少且未出现病毒反弹","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"1177639705","title":"TRAWS PHARMA公布Ratutrelvir與Paxlovid™對比的積極中期臨床數據,顯示對不適合使用Paxlovid患者的療效","url":"https://stock-news.laohu8.com/highlight/detail?id=1177639705","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1177639705?lang=zh_tw&edition=fundamental","pubTime":"2025-12-17 19:12","pubTimestamp":1765969951,"startTime":"0","endTime":"0","summary":"TRAWS PHARMA公布Ratutrelvir与Paxlovid™的对比数据,展示其在不适合使用Paxlovid的COVID-19患者中具有积极的疗效。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2586287406","title":"Traws Pharma, Inc.盤中異動 早盤急速拉升6.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586287406","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586287406?lang=zh_tw&edition=fundamental","pubTime":"2025-11-25 23:17","pubTimestamp":1764083863,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日23时17分,Traws Pharma, Inc.股票出现波动,股价大幅拉升6.17%。Traws Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.19%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家临床阶段的生物制药公司,致力于开发新型疗法,以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125231743a710ed57&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125231743a710ed57&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","TRAW"],"gpt_icon":0},{"id":"2582361182","title":"Traws Pharma, Inc.盤中異動 快速拉升12.25%報2.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582361182","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582361182?lang=zh_tw&edition=fundamental","pubTime":"2025-11-10 22:39","pubTimestamp":1762785575,"startTime":"0","endTime":"0","summary":"北京时间2025年11月10日22时39分,Traws Pharma, Inc.股票出现异动,股价快速拉升12.25%。Traws Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.67%。其相关个股中,Cogent Biosciences, Inc.、Inflarx N.V.、Pluri Inc.涨幅较大,Inflarx N.V.、Propanc Biopharma, Inc.、Innate Pharma较为活跃,换手率分别为78.46%、15.30%、8.72%,振幅较大的相关个股有Jasper Therapeutics Inc C/Wts 24/09/2026 、Cogent Biosciences, Inc.、Pluri Inc.,振幅分别为22.10%、20.18%、20.06%。Traws Pharma, Inc.公司简介:Traws Pharma Inc 是一家临床阶段的生物制药公司,致力于开发新型疗法,以针对呼吸道病毒性疾病对人类健康的关键威胁。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111022393594fb9650&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025111022393594fb9650&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"1157882863","title":"Chemdiv擴展與TRAWS PHARMA的Ratutrelvir的CMC服務合作,後者是一個在進行二期臨床試驗的潛在最佳Covid-19治療藥物","url":"https://stock-news.laohu8.com/highlight/detail?id=1157882863","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157882863?lang=zh_tw&edition=fundamental","pubTime":"2025-10-31 00:00","pubTimestamp":1761840050,"startTime":"0","endTime":"0","summary":"Chemdiv扩展与TRAWS PHARMA的Ratutrelvir的CMC服务合作,后者是一个在进行二期临床试验的潜在最佳Covid-19治疗药物","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"1184440960","title":"TRAWS PHARMA啓動Ratutrelvir二期新冠研究,首位患者已接受給藥,預計2025年底公布結果","url":"https://stock-news.laohu8.com/highlight/detail?id=1184440960","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184440960?lang=zh_tw&edition=fundamental","pubTime":"2025-10-14 19:00","pubTimestamp":1760439648,"startTime":"0","endTime":"0","summary":"TRAWS PHARMA启动Ratutrelvir二期新冠研究,首位患者已接受给药,预计2025年底公布结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRAW","BK4007"],"gpt_icon":0},{"id":"1119026861","title":"TRAWS PHARMA任命John Leaman醫學博士為獨立董事,並正式確認兩名核心高管職務","url":"https://stock-news.laohu8.com/highlight/detail?id=1119026861","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119026861?lang=zh_tw&edition=fundamental","pubTime":"2025-10-06 19:02","pubTimestamp":1759748565,"startTime":"0","endTime":"0","summary":"TRAWS PHARMA任命John Leaman医学博士为独立董事,并正式确认两名核心高管职务","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","TRAW"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}]}}